3-氟-5-三氟甲基苯硼酸 | 159020-59-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-氟-5-三氟甲基苯硼酸
• 中文别名: 3-氟-5-三氟甲基苯基硼酸；3-氟-5-(三氟甲基)苯硼酸
• 英文名称: (3-fluoro-5-(trifluoromethyl)phenyl)boronic acid
• 英文别名: [3-fluoro-5-(trifluoromethyl)phenyl]boronic acid
• CAS: 159020-59-4
• 化学式: C₇H₅BF₄O₂
• mdl: MFCD06657735
• 分子量: 207.92
• InChiKey: WEMCWZGCSRGJGW-UHFFFAOYSA-N

物化性质

• 熔点：
  168°C(lit.)
• 沸点：
  264.0±50.0 °C(Predicted)
• 密度：
  1.44±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.66
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.142
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  6

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2931900090
• 危险类别：
  IRRITANT
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H315,H319,H335

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
3-Fluoro-5-trifluoromethylphenylboronic acid
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P261: Avoid breathing dust/fume/gas/mist/vapours/spray
Wear protective gloves/protective clothing/eye protection/face protection
P280:
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

---

Section 3. Composition/information on ingredients.
3-Fluoro-5-trifluoromethylphenylboronic acid
Ingredient name:
CAS number: 159020-59-4

---

Section 4. First aid measures
Immediately wash skin with copious amounts of water for at least 15 minutes while removing
Skin contact:
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.
Ingestion:

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Not specified
Appearance:
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H5BF4O2
Molecular weight: 207.9

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen fluoride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氟-5-三氟甲基苯硼酸 在 亚硝酸特丁酯 、 1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 、 caesium carbonate 、 copper(ll) bromide 作用下， 以 1,4-二氧六环 、 水 、 乙腈 为溶剂， 反应 5.0h， 生成 2-bromo-8-(3-fluoro-5-(trifluoromethyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridine
  参考文献：
  名称：

  [EN] BRIDGED PIPERIDINE DERIVATIVES
  [FR] DÉRIVÉS DE PIPÉRIDINE PONTÉS

  摘要：

  本发明涉及式(I)的化合物；hetaryl是一个含有1至3个杂原子（O、S或N）的五元杂芳基团；R1是氢、卤素、低碳链烷基、低碳链烷氧基、被卤素取代的低碳链烷基、被卤素取代的S-低碳链烷基或被卤素取代的低碳链烷氧基，或者邻近的两个碳原子可在苯基上形成一个含有-O-CH2-O-的额外环；n为1至5；R2是氢或被卤素取代的低碳链烷基；R3是氢或被卤素取代的低碳链烷基；或其药用酸加合物、消旋混合物、对映体或光学异构体或立体异构体。这些化合物可用于治疗阿尔茨海默病、脑淀粉样血管病、遗传性脑出血伴淀粉样病变的荷兰型（HCHWA-D）、多梗塞性痴呆、拳击性痴呆或唐氏综合征。

  公开号：

  WO2017042114A1
• 作为产物：
  描述：

  3-溴-5-氟三氟甲苯 、 正丁基锂 、 硼酸三异丙酯 以to give 3-fluoro-5-trifluoromethylphenyl boronic acid的产率得到3-氟-5-三氟甲基苯硼酸
  参考文献：
  名称：

  Indole derivatives as 5-HT receptor antagonist

  摘要：

  本发明涉及具有药理活性的杂环化合物，其制备方法，包含它们的组合物以及在治疗中枢神经系统疾病，如焦虑症方面的应用。

  公开号：

  US06638953B2

文献信息

• Insecticidal substituted-2,4-diaminoquinazolines
  申请人：FMC Corporation

  公开号：US05534518A1

  公开（公告）日：1996-07-09

  An insecticidal composition comprising, in admixture with an agriculturally acceptable carrier, an insecticidally effective amount of a 2,4-diaminoquinazoline compound of the formula: ##STR1## wherein R.sup.1, R.sup.2, R.sup.6, R.sup.7, W, X, Y, and Z are as defined herein; methods of using the same; novel 2,4-diaminoquinazolines per se; and intermediates in the preparation thereof.

  一种含有农业上可接受载体的杀虫组合物，该组合物包含有效杀虫量的2,4-二氨基喹唑啉化合物，其化学公式如下：##STR1## 其中，R.sup.1、R.sup.2、R.sup.6、R.sup.7、W、X、Y和Z的定义如本文所述；使用该化合物的方法；新颖的2,4-二氨基喹唑啉本身；以及制备该化合物的中间体。
• Bicyclic sulfonamide compounds as sodium channel inhibitors
  申请人：AMGEN INC.

  公开号：US09212182B2

  公开（公告）日：2015-12-15

  The present invention provides compounds of Formula I, and pharmaceutically acceptable salts thereof, that are inhibitors of voltage-gated sodium channels, in particular Nav1.7. The compounds are useful for the treatment of diseases associated with the activity of sodium channels such as pain disorders and itch. Also provided are pharmaceutical compositions containing compounds of the present invention.

  本发明提供了式I的化合物及其药学上可接受的盐，这些化合物是钠通道的抑制剂，特别是Nav1.7。这些化合物对于治疗与钠通道活性相关的疾病，如疼痛障碍和瘙痒，是有用的。还提供了含有本发明化合物的药物组合物。
• 双环酮磺酰胺化合物
  申请人：美国安进公司

  公开号：CN107531705B

  公开（公告）日：2020-09-18

  本发明提供式(I)化合物，其中：式(II)为如本说明书中所定义的，其中：其对映异构体、非对映异构体、阻转异构体或其混合物或其药学上可接受的盐，这些化合物是电压门控钠通道、具体地为Nav 1.7的抑制剂。所述化合物适用于治疗可通过抑制钠通道治疗的疾病，例如疼痛病症、咳嗽或瘙痒症。本文还提供含有本发明化合物的药物组合物。
• Discovery and Optimization of a Novel 2<i>H</i>-Pyrazolo[3,4-d]pyrimidine Derivative as a Potent Irreversible Pan-Fibroblast Growth Factor Receptor Inhibitor
  作者：Yujiao Wei、Yanting Tang、Yunyun Zhou、Yuyu Yang、Yetong Cui、Xuan Wang、Yubo Wang、Yulin Liu、Ning Liu、Qianqian Wang、Chong Li、Hao Ruan、Honggang Zhou、Mingming Wei、Guang Yang、Cheng Yang

  DOI：10.1021/acs.jmedchem.1c00174

  日期：2021.7.8

  cancers. In fact, several selective irreversible inhibitors capable of covalently reacting with the conserved cysteine of FGFRs are currently being evaluated in clinical trials. In this article, we optimized and discovered a novel lead compound 36 with remarkable inhibitory effects against FGFR (1–3), which is a derivative of 2H-pyrazolo[3,4-d]pyrimidine. The irreversible binding to FGFRs was characterized

  成纤维细胞生长因子受体 (FGFR) 已成为各种类型癌症的有希望的治疗靶点。事实上，目前正在临床试验中评估几种能够与 FGFR 的保守半胱氨酸发生共价反应的选择性不可逆抑制剂。在本文中，我们优化并发现了一种对 FGFR (1-3) 具有显着抑制作用的新型先导化合物36，它是 2 H-吡唑并[3,4-d]嘧啶的衍生物。LC-MS 表征了与 FGFR 的不可逆结合。该化合物已被证明在体外和体内对 NCI-H1581 和 SNU-16 癌细胞系具有显着的抗增殖作用。化合物36 还证明了低毒性和足够的药代动力学特性，目前正在验证作为潜在的候选药物。
• [EN] NOVEL THYROMIMETICS<br/>[FR] NOUVEAUX THYROMIMÉTIQUES
  申请人：AUTOBAHN THERAPEUTICS INC

  公开号：WO2020180624A1

  公开（公告）日：2020-09-10

  Compounds are provided having the structure of Formula (I): or a pharmaceutically acceptable isomer, racemate, hydrate, solvate, isotope, or salt thereof, wherein A, X1, X2, Q, R1, R2 and n are as defined herein. Such compounds function as thyromimetics and have utility for treating diseases such as neurodegenerative disorders and fibrotic diseases. Pharmaceutical compositions containing such compounds are also provided, as are methods of their use and preparation.

  提供具有以下结构的化合物（I）的结构：或其药学上可接受的异构体、拉氏体、水合物、溶剂合物、同位素或盐，其中A、X1、X2、Q、R1、R2和n如本文所定义。这些化合物作为甲状腺类似物发挥作用，并可用于治疗神经退行性疾病和纤维化疾病等疾病。还提供含有这些化合物的药物组合物，以及它们的使用和制备方法。